Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-24

FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)

View source ↗

Summary

The FDA approved an original abbreviated new drug application (ANDA) for olmesartan medoxomil, with Quallent Pharmaceuticals Health LLC as the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)